Skip to main content
OpenTrials
Completed

NCT Number: NCT03157440

Novel Device for Screening Patients With Symptoms of OSA

An innovative ring type oxymetry will be wore by patient undergoing sleep study to validate it's accuracy and usefulness as a screening device for patients with symptoms of OSA

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Medicine and Therapeutics, Prince of Wales Hospital, CUHK

Hong Kong

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients above 18 years old and below 70 years old, both men and women

Exclusion criteria

  • Patients requiring oxygen therapy or noninvasive ventilation;
  • Patients with a diagnosis of chronic obstructive pulmonary disease, chronic heart failure, neuromuscular disease, insomnia, clinical symptoms of parasomnia, periodic limb movement, or narcolepsy.
  • Patients on medication known to interfere with heart rate, such as beta-blockers, digoxin or calcium receptor antagonists.

Treatment and study plan

Ring oxymetry

Diagnostic Test

a new type oxymetry wear on index finger like a ring

Primary outcomes

  1. the concordance of the ring oximetry with PSG as the gold standard

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Official study title

Validation of a Novel Device for Screening Patients With Symptoms of OSA

Important dates

Study start
2017
Primary completion
2017
Study completion
2018
First posted
May 17, 2017
Registry last updated
Apr 17, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.